Skip to main content
Northwestern University Feinberg School of Medicine

Peering Over The Horizon: The Future of Targeted Therapies

2026 OncoSET Symposium

Register for March 6, 2026

On Friday, March 6, the Lurie Cancer Center OncoSET program will hold its annual symposium on new advances in precision medicine.  This year's theme is Peering Over The Horizon: The Future of Targeted Therapies.  Please join us for this informative and practical symposium.

Event Details

Participants attend the OncoSET symposium

Friday, March 6, 2026

8:00 a.m. - 9:00 a.m.
Registration, Exhibits & Breakfast

9:00 a.m. - 2:35 p.m.
Program

Agenda
Feinberg Pavilion

Northwestern Memorial Hospital

IN PERSON

Feinberg Pavilion, 3rd Floor Conference Center
251 E. Huron St., Chicago

Register

Topics & Speakers

The Evolution of Targeted Therapy
Pedro A Hermida de Viveiros, MD
Northwestern University

EGFR Inhibition – Old Target, New Strategies
Christine Bestvina, MD
University of Chicago

Claudins and Met, New Targets in Town
Deva Mahalingam, MD, PhD
Northwestern University 

Expanding our Target Options
– KRAS and MTAP
Chengwei Peng, MD
Northwestern University

The Evolution of Targeted Therapy
David VanderWeele, MD, PhD
Northwestern University

Topics & Speakers

Antigen-Directed Therapy for Bladder Cancer
Randy Sweis, MD
University of Chicago

Advances in Genomic Landscape of CNS Tumors: Implications for Treatment and Prognosis
Madina Sukhanova, MD
Northwestern University

Targeted Therapy for Lymphoma
Nazila Shafagati, MD
University of Chicago

CHIP – What Do We Do With This Result?
Alok Swaroop, MD, PhD
Northwestern University


Conference Fees

Lurie Cancer Center Affiliate Rates
Affiliates include Northwestern University, Northwestern Medicine, Lurie Children's, Shirley Ryan AbilityLab, and Jesse Brown VA.
  Student, Fellow or Resident Complimentary
  Nurse or Allied Health Professional $25
  Research Staff $25
  Faculty and/or Physician $50
General Rates
  Student, Fellow or Resident Complimentary
  Nurse or Allied Health Professional $50
  Research Staff $50
  Faculty and/or Physician $75
  Industry Representative $250

All participants must register in advance to receive connection information.

Conference Chair

David VanderWeele, MD, PhD
Northwestern University

Accreditation Information

Target Audience

This activity is intended for healthcare professionals involved in the treatment and care of patients with advanced or refractory cancers for whom precision medicine can help guide treatment choices. This includes medical, surgical, and radiation oncologists, pathologists, radiologists, other translational-oriented laboratory scientists, nurses, pharmacists, genetic counselors, and physician assistants.

Objectives

  1. Learn about new targeted small molecules
  2. Implement new strategies for biomarker-driven therapies
  3. Discuss prioritization of biomarker-driven therapies

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Faculty Disclosure

Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker's presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off-label usage will be indicated in the course syllabus.

Additional Information

For additional information about the event, please contact us at cancer@northwestern.edu or 312-503-7809.

See also the OncoSET Precision Medicine webpage.